The coronavirus may be new, but the most effective means of prevention are not.
OMRF researchers have identified the exact origin point of movement within chromosomes for the first time.
Typically, a promising new experimental drug arrives on the scene with a flourish. But sometimes, it’s a long and winding road.
The findings will allow for more targeted treatment approaches.
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
The findings will help push clinicians closer to personalized medicine for lupus sufferers.